HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical study of the combination of small amount of nedaplatin (CDGP)/5-FU with radiation for the treatment of esophageal cancer].

Abstract
Recently chemoradiotherapy for esophageal cancer has been drawing public attention to the issue of quality of life maintenance for patients. Although the standard method of chemoradiotherapy is CDDP/5FU, it has been claimed that CDGP (a derivative of CDDP) alone is more effective than CDDP for the treatment of esophageal cancer due to its low nephro- and digestive toxicity. We used a small amount of CDGP/5-FU in combination with radiation instead of CDDP, for the treatment of esophageal cancer and performed clinical examination of patients. The partial response rate was 80% and the complete response rate was 50%. Major side-effects were leukopenia, neutropenia, thrombocytopenia and anemia. Further study of dosage and schedule is necessary, however, CDGP/5-FU combined with radiation therapy could be used as choices of chemoradiotherapy for esophageal cancer in the future.
AuthorsHiroyuki Inaba, Takashi Tsuda, Aya Miyazaki, Yoshiyuki Watanabe, Shinichi Nakaya, Yu Koitabashi, Kyoko Ogihara, Takefumi Hara, Naoyuki Kato, Yutaro Kobayashi, Teisuke Nakagawa, Satoshi Kitajima, Toru Endo, Shiro Iino, Yoshikazu Hoshikawa
JournalNihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology (Nihon Shokakibyo Gakkai Zasshi) Vol. 99 Issue 10 Pg. 1191-6 (Oct 2002) ISSN: 0446-6586 [Print] Japan
PMID12415854 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Organoplatinum Compounds
  • nedaplatin
  • Fluorouracil
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy, radiotherapy, therapy)
  • Combined Modality Therapy
  • Drug Administration Schedule
  • Esophageal Neoplasms (drug therapy, radiotherapy, therapy)
  • Female
  • Fluorouracil (administration & dosage)
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Organoplatinum Compounds (administration & dosage)
  • Radiotherapy Dosage

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: